Prostate Stem Cells and Benign Prostatic Hyperplasia

door Isaacs, John T.
Gepubliceerd in 2008

The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer

door Isaacs, John T
Gepubliceerd in 2010

Lessons Learned About Prostatic Transformation from the Age-Related Methylation of 5α-Reductase Type 2 Gene

door Isaacs, John T.
Gepubliceerd in Am J Pathol (2015)

Resolving the Coffey Paradox: what does the androgen receptor do in normal vs. malignant prostate epithelial cells?

door Isaacs, John T
Gepubliceerd in Am J Clin Exp Urol (2018)

Checks and balances occur not only in government, but also in biology

door Isaacs, John T.
Gepubliceerd in Oncotarget (2018)

Antibody engineering to develop new antirheumatic therapies

door Isaacs, John D
Gepubliceerd in 2009

The “Infectious” Nature of Human Prostate Cancer: A Cautionary Note

door Sfanos, Karen S., Isaacs, John T.
Gepubliceerd in 2011

Novel immunotherapies for rheumatoid arthritis

door Richardson, Sarah, Isaacs, John
Gepubliceerd in Clin Med (Lond) (2013)

The novel use of combined IL-1 and IL-6 inhibition in a patient with severe, aggressive, erosive, systemic-onset juvenile idiopathic arthritis

door Lee, Martin, Isaacs, John
Gepubliceerd in Eur J Rheumatol (2017)

Tissue Culture Media Supplemented with 10% Fetal Calf Serum Contains a Castrate level of Testosterone

door Sedelaar, JP Michiel, Isaacs, John T
Gepubliceerd in 2009

Engineering Enzymatically Activated “Molecular Grenades” for Cancer

door Denmeade, Samuel R., Isaacs, John T.
Gepubliceerd in 2012

Bipolar AndrogenTherapy: The Rationale for Rapid Cycling of Supraphysiologic Androgen/Ablation in Men With Castration Resistant Prostate Cancer

door Denmeade, Samuel R., Isaacs, John T.
Gepubliceerd in 2010

A history of prostate cancer treatment

door Denmeade, Samuel R., Isaacs, John T.
Gepubliceerd in 2002

Mesenchymal stem cells and the embryonic reawakening theory of BPH

door Brennen, W. Nathaniel, Isaacs, John T.
Gepubliceerd in Nat Rev Urol (2018)

Human Prostate Cancer Initiating Cells Isolated Directly From Localized Cancer Do Not Form Prostaspheres in Primary Culture

door Chen, Shuangling, Principessa, Lorenzo, Isaacs, John T.
Gepubliceerd in 2012

Prospects for Therapeutic Tolerance in Humans

door Baker, Kenneth F, Isaacs, John D
Gepubliceerd in Curr Opin Rheumatol (2014)

Induction of Programmed Death/Apoptosis in Androgen‐dependent Mouse Mammary Tumor Cell Line (Shionogi Carcinoma 115) by Androgen Withdrawal

door Furuya, Yuzo, Isaacs, John T., Shimazaki, Jun
Gepubliceerd in Jpn J Cancer Res (1995)

Tolerising cellular therapies: what is their promise for autoimmune disease?

door Mosanya, Chijioke H, Isaacs, John D
Gepubliceerd in Ann Rheum Dis (2019)

Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs

door Isaacs, John D, Burmester, Gerd R
Gepubliceerd in Ann Rheum Dis (2020)

2-fluoro-5-maleimidobenzoic acid-linked albumin drug (MAD) delivery for selective systemic targeting of metastatic prostate cancer

door Akinboye, Emmanuel S., Rogers, Oliver C., Isaacs, John T.
Gepubliceerd in Prostate (2018)